🔎 Trials Near Me

Início › Sobrepeso › Illinois

Ensaios clínicos de Sobrepeso em Illinois

38 estudos para Sobrepeso estão buscando participantes em locais em Illinois.

Cidades em Illinois

Texto oficial do estudo (Inglês)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • Charter Research LLC - Chicago, Chicago
  • Flourish Research - Chicago, Chicago
  • AMR Clinical - Chicago Oak Brook, Oak Brook
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Great Lakes Clinical Trials, Chicago
  • Clinical Investigation Spec Gurnee, Gurnee
  • Endeavor Health, Skokie
  • e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Chicago Research Center, Inc, Chicago
  • Endeavor Health, Skokie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07668414

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • Christie Clinic, Champaign
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Great Lakes Clinical Trials - Ravenswood, Chicago
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
  • Endeavor Health - Family Medicine Administration, Evanston
  • e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Champaign
  • Research Site, Chicago
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Rush University Medical Center, Chicago
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Rush University Medical Center, Chicago
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Endeavor Health-Northwest Community Healthcare, Arlington Heights
  • Eagle Clinical Research, Chicago
  • University of Chicago, Chicago
  • e mais 2
RecrutandoFase 3
Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Great Lakes Clinical Trials - Ravenswood, Chicago
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07392190

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Great Lakes Clinical Trials - Ravenswood, Chicago
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07589608

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Great Lakes Clinical Trials - Ravenswood, Chicago
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • NorthShore University Health System, Skokie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Chicago
  • Research Site, Melrose Park
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Schaumburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Schaumburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Elevate Clinical Research, Gurnee
  • Knownwell, Schaumburg
  • Endeavor Health, Skokie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Great Lakes Clinical Trials - Ravenswood, Chicago
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06143956

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

  • Walgreens - Store 11760, Oak Park
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07745504

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Springfield
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Flourish Research - Great Lakes Clinical Trials, Chicago
  • Endeavor Health, Skokie
  • Evanston Premier Healthcare Research LLC, Skokie
RecrutandoFase 3
Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Skokie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901

BRIDGE & Friends Trial

  • University of Illinois Chicago, Chicago
RecrutandoVoluntários saudáveis bem-vindos
Idades de 50 a 79 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07798557

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Endeavor Health, Skokie
RecrutandoFase 3
Idades de 18 a 99 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

  • Illinois Institute of Technology, Chicago
RecrutandoVoluntários saudáveis bem-vindos
Idades de 21 a 74 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Champaign
  • Research Site, Chicago
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Clinical Investigation Spec Gurnee, Gurnee
  • Evanston Premier Hlthcr Res, Skokie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Chicago
RecrutandoFase 3
Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

  • Jesse Brown VA Medical Center, Chicago
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • e mais 1
RecrutandoFase 2
Todas as idades · Todos os sexos · Atualizado em 10 de jul. de 2026 · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Recrutando
Idades de 18 a 40 · Mulheres · Atualizado em 9 de jul. de 2026 · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

  • Northwestern Memorial Hospital, Chicago
RecrutandoEstudo observacional
Idades de 18 a 70 · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

  • University of Chicago, Chicago
RecrutandoFase 3
Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de nov. de 2025 · NCT06499857

Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.